Stem Cell Therapy for Diabetes Mellitus

Stem Cell Therapy for Diabetes Mellitus

​

Diabetes Mellitus is a chronic condition that affects multiple systems in the body. It is characterized by elevated glucose (blood sugar) levels, which can damage small blood vessels responsible for maintaining the health of the eyes, kidneys, and peripheral nerves. This damage can also impair the body’s ability to heal wounds, often leading to complications such as diabetic foot.

​

Our stem cell therapy for Diabetes Mellitus uses allogeneic mesenchymal stem cells (MSCs). These cells are administered to help restore insulin-producing function, improve blood circulation, stimulate the formation of new blood vessels, and repair damaged vascular structures.

​

​

Potential Benefits of Stem Cell Therapy in Diabetes

​

The outcomes of stem cell therapy may differ from patient to patient, as they depend on factors such as overall health, medical history, and the extent of vascular and tissue damage. Research suggests that MSC therapy shows strong potential in regenerating blood vessels and repairing tissues affected by diabetes, with some of the most encouraging efficacy rates reported to date.

​

However, it is important to maintain realistic expectations. While stem cell therapy can support recovery and significantly improve quality of life, it should not be regarded as a guaranteed cure for diabetes. Instead, it offers an innovative therapeutic option that may complement existing treatments and help reduce diabetes-related complications.